THE EFFECT OF TREATMENT WITH MAGNETIC STIMULATION ON THE CONCENTRATION OF INTERLEUKIN-6, MORPHOLOGICAL PARAMETERS OF BLOOD AND CRP IN COVID-19 PATIENTS: PRELIMINARY RESULTS

Aim: The purpose of this study was to evaluate the efficacy of low-frequency magnetic field in the hybrid treatment of COVID-19 patients, i.e., including magnetic stimulation in the standard treatment. Materials and Methods: In the study groups, the patients were subjected to magnetic field - magnetic stimulation with the use of apparatus Viofor JPS System. In laboratory tests, the following levels were assessed in the patients: interleukin 6 (IL -6), leukocytes (WBC), monocytes (MONO), platelets (PLT) and CRP. Results: In patients hospitalized for COVID-19 who received magnetic stimulation treatments with the use of the Viofor JPS System device, a statistically significant reduction in proinflammatory IL-6 levels was achieved (28.72 vs. 6.05 pg/ml, p=0.008). In the study group (with magnetic stimulation) we also observed a higher number of monocytes (MONO) with a more stable level of leukocytes (WBC) compared to the control group (without magnetic stimulation). Conclusions: It is probable that the application of low-frequency magnetic field in the hybrid treatment of COVID-19 patients may reduce pro-inflammatory factors (IL- 6). The low frequency magnetic fields are capable of restoring body homeostasis in terms of parameters evaluated in laboratory tests (WBC, MONO, PLT, CRP) which requires further research.